Cargando…
Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”
Current vaccination against Streptococcus pneumoniae uses vaccines based on capsular polysaccharides from selected serotypes and has led to nonvaccine serotype replacement disease. We have investigated an alternative serotype-independent approach, using multiple-antigen vaccines (MAV) prepared from...
Autores principales: | Chan, Win-Yan, Entwisle, Claire, Ercoli, Giuseppe, Ramos-Sevillano, Elise, McIlgorm, Ann, Cecchini, Paola, Bailey, Christopher, Lam, Oliver, Whiting, Gail, Green, Nicola, Goldblatt, David, Wheeler, Jun X., Brown, Jeremy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199499/ https://www.ncbi.nlm.nih.gov/pubmed/35076289 http://dx.doi.org/10.1128/IAI.00846-18a |
Ejemplares similares
-
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge
por: Chan, Win-Yan, et al.
Publicado: (2019) -
Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection
por: Huang, Jiachen, et al.
Publicado: (2021) -
Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4(+) T Cells
por: van de Garde, Martijn D. B., et al.
Publicado: (2019) -
Vaccination against Clostridium difficile by Use of an Attenuated Salmonella enterica Serovar Typhimurium Vector (YS1646) Protects Mice from Lethal Challenge
por: Winter, Kaitlin, et al.
Publicado: (2019) -
Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Streptococcus suis Serotypes 3, 7, 8, and 9: the Serotype 3 Polysaccharide Induces an Opsonizing IgG Response
por: Goyette-Desjardins, Guillaume, et al.
Publicado: (2020)